Aquestive Therapeutics in Indianapolis is seeking a Therapeutic Specialty Representative (TSR) to lead the launch of Anaphylm, a potentially first-in-class FDA-approved epinephrine product for severe allergic reactions.
You will educate providers, build payor strategies, and drive access while navigating the launch environment with a focused, results-driven mindset. Travel up to 50% and close collaboration with cross-functional teams is expected.
#J-18808-Ljbffr
As a Therapeutic Specialty Representative — Launch & Access, you will play an important part at Aquestive Therapeutics, Inc. in Indianapolis, IN, United States.
Join Aquestive Therapeutics, Inc. and contribute to our ongoing work.
Take a moment to read everything above and see whether this role is right for you.
This posting is for the Therapeutic Specialty Representative — Launch & Access role at Aquestive Therapeutics, Inc., based in Indianapolis, IN, United States.